Comparison of laparoscopy and laparotomy for the management of early-stage ovarian cancer: surgical and oncological outcomes.
10.3802/jgo.2014.25.2.111
- Author:
Yu Jin KOO
1
;
Jung Eun KIM
;
Young Hwa KIM
;
Ho Suap HAHN
;
In Ho LEE
;
Tae Jin KIM
;
Ki Heon LEE
;
Jae Uk SHIM
;
Kyung Taek LIM
Author Information
1. Department of Obstetrics and Gynecology, Cheil General Hospital and Women's Healthcare Center, Kwandong University College of Medicine, Seoul, Korea. oncolim@korea.com
- Publication Type:Original Article
- Keywords:
Early-stage ovarian cancer;
Laparoscopy surgery;
Laparotomy staging
- MeSH:
Disease-Free Survival;
Follow-Up Studies;
Humans;
Hysterectomy;
Laparoscopy*;
Laparotomy*;
Lymph Node Excision;
Ovarian Neoplasms*;
Postoperative Complications;
Recurrence;
Retrospective Studies
- From:Journal of Gynecologic Oncology
2014;25(2):111-117
- CountryRepublic of Korea
- Language:English
-
Abstract:
OBJECTIVE: To investigate the surgical and oncological outcomes of laparoscopic surgery compared with laparotomy for the treatment of early-stage ovarian cancer. METHODS: Data from patients who underwent surgical management for early-stage ovarian cancer between 2006 and 2012 were retrospectively reviewed. All patients presented with stage I or II disease, and underwent comprehensive staging surgery consisting of a total hysterectomy, bilateral salpingo-oophorectomy, pelvic and para-aortic lymphadenectomy, omentectomy, and peritoneal cytology. RESULTS: Seventy-seven patients who underwent laparoscopic surgery (24 patients) or laparotomy (53 patients) were identified. Surgery for none of the patients was converted from laparoscopy to laparotomy. The mean operation time was shorter and the estimated blood loss was lower in the laparoscopy group than in the laparotomy group, though the differences were not statistically significant (193 min vs. 224 min, p=0.127; 698 mL vs. 973 mL, p=0.127). There were no differences in the intraoperative or postoperative complications. During a mean follow-up period of 31 months, tumor recurrence occurred in 4 patients: 2 (8.3%) in the laparoscopy group and 2 (3.8%) in the laparotomy group. The mean disease-free survival was 59 months after laparoscopy and 66 months after laparotomy (p=0.367). CONCLUSION: Laparoscopic surgery seems to be adequate and feasible for the treatment of early-stage ovarian cancer with comparable results to laparotomy in terms of the surgical outcomes and oncological safety.
